We are live on
!
Find out more
Zurich Cantonal Bank Portfolio holdings
AUM
$46B
1-Year Est. Return
27.59%
This Fund
S&P 500
This Quarter
Est. Return
+3.36%
1 Year Est. Return
+27.59%
3 Year Est. Return
+97.89%
5 Year Est. Return
+132.69%
10 Year Est. Return
+500.34%
AUM
$35.1B
AUM Growth
+$1.49B
(+4.4%)
Cap. Flow
+$1.2B
Cap. Flow
% of AUM
3.42%
Top 10 Holdings %
Top 10 Hldgs %
34.43%
Holding
2,712
New
61
Increased
1,569
Reduced
471
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$91.2M |
| 2 |
Cisco
CSCO
|
+$88.8M |
| 3 |
CME Group
CME
|
+$88.4M |
| 4 |
Tesla
TSLA
|
+$81.2M |
| 5 |
Apple
AAPL
|
+$76.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$189M |
| 2 |
Applied Materials
AMAT
|
+$78.6M |
| 3 |
Elevance Health
ELV
|
+$75.3M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$56M |
| 5 |
D.R. Horton
DHI
|
+$50.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.43% |
| 2 | Financials | 16.87% |
| 3 | Healthcare | 11.59% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALX
2526
Alexander's
ALX
$1.38B
| $21.6K | ﹤0.01% |
108
| – | – |
|
|
FLNA
2527
Filana Therapeutics
FLNA
$48.2M
| $21.4K | ﹤0.01% |
9,069
+1,602
| +21% | +$28.1K |
|
|
ITOS
2528
DELISTED
iTeos Therapeutics
ITOS
| $19.8K | ﹤0.01% |
2,574
-9,354
| -78% | -$80.4K |
|
2529
Mesa Laboratories
MLAB
$569M
| $19.5K | ﹤0.01% |
148
| – | – |
|
|
JKS
2530
JinkoSolar
JKS
$886M
| $19.4K | ﹤0.01% |
780
+57
| +8% | +$1.39K |
|
2531
Vitamin Cottage Natural Grocers
NGVC
$605M
| $18.1K | ﹤0.01% |
455
-329
| -42% | -$11.4K |
|
|
DQ
2532
Daqo New Energy
DQ
$989M
| $17.2K | ﹤0.01% |
883
| – | – |
|
2533
Hyster-Yale Materials Handling
HY
$629M
| $17.1K | ﹤0.01% |
336
| – | – |
|
2534
Ascendis Pharma A/S
ASND
$16.8B
| $15.6K | ﹤0.01% |
113
-26
| -19% | -$3.42K |
|
2535
GlobalFoundries
GFS
$27.5B
| $14.7K | ﹤0.01% |
342
-162
| -32% | -$6.79K |
|
2536
Codexis
CDXS
$161M
| $14.3K | ﹤0.01% |
2,997
-496
| -14% | -$2.04K |
|
|
OTLY
2537
Oatly Group
OTLY
$419M
| $14.3K | ﹤0.01% |
1,078
-138
| -11% | -$2.03K |
|
2538
Angi Inc
ANGI
$186M
| $14K | ﹤0.01% |
843
| – | – |
|
|
THRD
2539
DELISTED
Third Harmonic Bio
THRD
| $13.1K | ﹤0.01% |
1,275
-296
| -19% | -$3.69K |
|
2540
MaxCyte
MXCT
$130M
| $12.2K | ﹤0.01% |
2,935
-29,800
| -91% | -$113K |
|
2541
Limoneira
LMNR
$249M
| $11.9K | ﹤0.01% |
487
+352
| +261% | +$9.41K |
|
2542
MeiraGTx Holdings
MGTX
$1.21B
| $11.8K | ﹤0.01% |
1,941
-410
| -17% | -$2.4K |
|
|
KALV
2543
DELISTED
KalVista Pharmaceuticals
KALV
| $9.86K | ﹤0.01% |
1,164
-247
| -18% | -$2.56K |
|
2544
AstraZeneca
AZN
$251B
| $9.83K | ﹤0.01% |
75
| – | – |
|
2545
Consolidated Water Co
CWCO
$484M
| $9.76K | ﹤0.01% |
377
+74
| +24% | +$1.89K |
|
|
GRFS
2546
Grifois
GRFS
$5.48B
| $9.71K | ﹤0.01% |
1,305
-277
| -18% | -$2.31K |
|
2547
British American Tobacco
BTI
$123B
| $9.55K | ﹤0.01% |
263
| – | – |
|
2548
AC Immune
ACIU
$232M
| $8.43K | ﹤0.01% |
3,123
-540
| -15% | -$1.69K |
|
2549
Editas Medicine
EDIT
$432M
| $8.22K | ﹤0.01% |
6,472
-16,978
| -72% | -$43.3K |
|
2550
Zegna
ZGN
$3.97B
| $7.7K | ﹤0.01% |
932
| – | – |
|
Similar funds
LP
TI
Zurich Cantonal Bank's Q4 2024 Portfolio in Review
As of Q4 2024, Zurich Cantonal Bank held 2,712 positions worth $35.1B, up 4.4% from $33.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Zurich Cantonal Bank deployed $1.2B of net new capital in Q4 2024, opening 61 new positions and adding to 1,569 existing holdings. Its largest new stake was iShares S&P Small-Cap 600 Growth ETF: 15,903 shares worth $2.16M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was UBS Group, an estimated $189M trimmed.
- Zurich Cantonal Bank's largest Q4 2024 buy was iShares S&P Small-Cap 600 Growth ETF: 15,903 shares worth $2.16M.
- Zurich Cantonal Bank added most to JPMorgan Chase in Q4 2024, an estimated $91.2M increase.
- Zurich Cantonal Bank's biggest Q4 2024 reduction was UBS Group, cutting an estimated $189M.
- Zurich Cantonal Bank fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $21M.
- Zurich Cantonal Bank's ten largest holdings make up 34% of its $35.1B portfolio in Q4 2024.
- Zurich Cantonal Bank opened 61 new positions and closed 67 in Q4 2024.
- Zurich Cantonal Bank's portfolio value rose 4.4% quarter-over-quarter to $35.1B.
Based on Zurich Cantonal Bank's 13F filing for Q4 2024, filed 7 Feb 2025.